Positive impactCompany
Already up 137% in 1 year still JM Financial sees more upside in this stock | Check target price, shareholding pattern
Mint 1 hr ago·10 Sept 2026, 11:49 am
JM Financial has maintained a 'buy' rating on Acutaas Chemicals, setting a target price of ₹3,800. This comes despite the stock's significant rally of over 137% in the past year, suggesting the brokerage firm sees continued room for growth in the company's future.
For investors, this rating signals that Acutaas Chemicals remains a strong contender in its sector. The firm's confidence implies that the current market price may not yet fully reflect the company's potential, making it a stock to monitor closely for further developments.
Moving forward, investors should watch the company's quarterly results and any updates on its expansion plans. These factors will be crucial in determining whether the stock can sustain its momentum and reach the target price set by JM Financial.
Excerpt from Mint
With a staggering 137% rise in the past year, Acutaas Chemicals continues to draw attention from investors. JM Financial recently reinstated a buy rating with a target price of ₹ 3,800, indicating more potential growth. Speciality chemical stock, Acutaas Chemicals, has given stellar rewards to its investors, and it…Read the original at Mint
Affected stocks
Bullish2 stocks
Bull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.
Key takeaways
- Concerns JM Financial (JMFINANCIL).
- Category: Company.
- AI reads the tone as positive (potentially bullish) for the stock.
- Also mentions ACUTAAS.
Why it matters
A routine update for JM Financial. The tone is positive — historically associated with upward pressure, though not predictive. Use the price and stock snapshot to gauge how the market is responding.
